Improved prognosis with integrated care management including early rhythm control and healthy lifestyle modification in patients with concurrent atrial fibrillation and diabetes mellitus

Back

EHRA Premium Access

Improved prognosis with integrated care management including early rhythm control and healthy lifestyle modification in patients with concurrent atrial fibrillation and diabetes mellitus

Session: Atrial Fibrillation - Round 1 - Drugs, Prevention

Topic: Rhythm Control, Hybrid Therapy

Speaker: Doctor H. Ahn (Seoul, KR)

Event: EHRA 2023

Congress Presentation

Add to my library

About the speaker

Doctor Hyojeong Ahn

Seoul National University Hospital, Seoul (Korea (Republic of))

3 followers

5 more presentations in this session

Atrial fibrillation screening to prevent stroke in patients with high NT-proBNP - a post-hoc analysis of the randomized LOOP study

Speaker: Doctor S. Diederichsen (Copenhagen, DK)

Atrial fibrillation is an independent risk factor for heart failure progression and pump failure mortality in HFpEF:: a propensity score matched analysis of the TOPCAT Americas study

Speaker: Professor D. Shah (Geneva, CH)

Effects of antiarrhythmics on atrial high rate episodes and progression to clinical atrial fibrillation (ANTI-AHRE)

Speaker: Doctor S. Simovic (Kragujevac, RS)

Atrial fibrillation and in-hospital mortality in Covid-19 patients

Speaker: Doctor I. Kotadia (London, GB)

Active monitoring for atrial fibrillation (AMALFI): a streamlined randomised controlled trial of remote screening for subclinical atrial fibrillation

Speaker: Doctor R. Wijesurendra (Oxford, GB)

Access the full session

Atrial Fibrillation - Round 1 - Drugs, Prevention

Speakers: Doctor H. Ahn, Doctor S. Diederichsen, Professor D. Shah, Doctor S. Simovic, Doctor I. Kotadia...

Access

Video

About the event

EHRA 2023

16 April - 18 April 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources